Drug Discovery & Research
The Invisible Proteome: How 1,000 Hidden Brain Molecules Could Rewrite Alzheimer's Drug Discovery
Salk Institute researchers unveil a previously undetected class of microproteins that change independently in Alzheimer's disease, exposing critical blind spots in current therapeutic development.
Health AI Central Editorial Team·September 21, 2026